drugset / Trial / NCT00918645

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis

NCT00918645 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

RATIONALE: Diagnostic procedures, such as radionuclide imaging using calcium-41 (41Ca) chloride aqueous solution, may help predict progressive disease in patients with prostate cancer and bone metastasis. PURPOSE: This clinical trial is studying how well calcium-41 (41Ca) chloride aqueous solution works in diagnosing patients with prostate cancer and bone metastasis.

Timeline

Start
2009-09
Primary completion
2013-01
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject 41Ca Diagnostic / imaging agent 1.2 ug Oral